ACP
AGN

Ashfield Capital Partners’s Allergan Inc AGN Stock Holding History

Ashfield Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,106
Closed -$2.57M – 277
2014
Q4 		$2.57M Hold
12,106
– – 0.12% 101
2014
Q3 		$2.16M Sell
12,106
-160
-1% -$26.6K 0.1% 110
2014
Q2 		$2.08M Sell
12,266
-733
-6% -$114K 0.1% 115
2014
Q1 		$1.61M Sell
12,999
-844
-6% -$103K 0.08% 125
2013
Q4 		$1.54M Sell
13,843
-129,627
-90% -$12.4M 0.07% 126
2013
Q3 		$13M Sell
143,470
-3,201
-2% -$287K 0.67% 57
2013
Q2 		$12.4M Buy
+146,671
New +$15.2M 0.67% 57

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Ashfield Capital Partners's AGN Position: Q1 2015 in Review

Ashfield Capital Partners sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 12,106 shares — an estimated $2.57M sold.

Ashfield Capital Partners first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $13M in Q3 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Ashfield Capital Partners reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Ashfield Capital Partners sold 12,106 Allergan Inc shares in Q1 2015, an estimated $2.57M.
  • Ashfield Capital Partners first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Ashfield Capital Partners's Allergan Inc position peaked at $13M in Q3 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Ashfield Capital Partners's 13F filing for Q1 2015, filed 7 May 2015.